home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Implementing GEP (Good Engineering Practices) in the Pharmaceutical, Bio-Pharmaceutical, and Medical Device Industries

 
  February 18, 2009  
     
 
The Center for Professional Advancement, 90 minute Accredited Online Training
March 24, 2009 at 11:00 a.m. - 12:30 p.m. (EST)


Who Should Attend
This course is intended for Engineering Unit Managers and interdisciplinary Project Team Members who are responsible to deliver “Fit for Intended Use” cGMP manufacturing, R&D, and supporting facilities. The course is recommended for:

  • Engineering Managers
  • Project Managers
  • Quality Unit Managers
  • Commissioning & Qualification Project Team Leaders
  • Engineering Design Service Providers
  • Construction Managers
  • Compliance Service Providers

Description
This 90-minute accredited online course is aligned with current industry “Risk-Based” initiatives and guidance provided in ICH Q9, ASTM E2500, and ISPE Baseline & Good Practice Guides. This course will provide insight on critical project decision making and enable a project team to identify and document data during the application of GEPs during the design, specification, and verification phases of a project. Discussions will focus on identifying and implementing Engineering Quality Systems to assure efficiency and quality.

Module 1:
  • GEP Overview
  • Engineering Quality Systems
  • GMP and GEP

Module 2: 
  • Design Review Process
  • Change Management
  • Risk Management

Module 3: 
  • Applying GEP to the Verification (Commissioning 
     & Qualification)
  • Integrating the Project and Engineering Lifecycles
  • Planning for Success

Question and Answer Session

 
 
Organized by: The Center for Professional Advancement
Invited Speakers: Steven Wisniewski, Senior Associate, Director of Compliance Services, IPS (Integrated Project Services)

Steven J. Wisniewski is a Senior Associate and Director of Compliance for Integrated Project Services (IPS), a full service-engineering firm specializing in the delivery of technical complex projects, which offers complete design/build, commissioning, validation and FDA compliance services for the pharmaceutical, biotech, health care and specialty manufacturing industries.

He offers more than 30 years experience in the pharmaceutical, biotech, and device industries. Prior to joining IPS, Mr. Wisniewski was Senior Consultant for Drug and Device Associates and has served in senior management roles at Sterling Winthrop and Bausch & Lomb. He has completed a wide variety of pharmaceutical manufacturing, filling and critical support operations to major R&D laboratories, facilities and upgrades. He served as a member of the ASTM Task Team that developed the International Consensus Standard for Verification (C&Q). Mr. Wisniewski holds a BSME from Rensselaer Polytechnic Institute, is a member of PDA and an active member of ISPE. He served on the ISPE Board of Directors beginning in 1982, served as Chairman of the Board in 1991 and currently serves as Chairman of the ISPE Community of Practice for Commissioning and Qualification and also serves on a Task Team in the process of drafting the new ISPE Baseline Guide for Installation and Verification (C&Q).

ADDITIONAL FACULITY:
Chuck Stock, Senior Vice President, IPS
Vince Cebular, Senior Director of Operations, Compliance Services, IPS
 
Deadline for Abstracts: N/A
 
Registration: Please click here for registration information.
E-mail: salbers@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.